Cyanotech Corporation (NASDAQ:CYAN) Receiving Somewhat Favorable Press Coverage, Analysis Finds
Headlines about Cyanotech Corporation (NASDAQ:CYAN) have trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cyanotech Corporation earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned news stories about the biotechnology company an impact score of 46.8147167117999 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
These are some of the media headlines that may have impacted Accern’s scoring:
- CYANOTECH : Transcript of August 11 earnings call for Q1 FY 18 (4-traders.com)
- Cyanotech Corporation’s (CYAN) CEO Gerry Cysewski on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com)
- Cyanotech Corporation (CYAN) Posts Quarterly Earnings Results (americanbankingnews.com)
- U.S. STOCKS ON THE MOVE-Department store stocks, Blue Apron, Perrigo, Chicago Bridge (timesofindia.indiatimes.com)
- Mid-Day Market Update: Babcock & Wilcox Drops After Q2 Results; Hudson Technologies Shares Surge (nasdaq.com)
Separately, ValuEngine raised Cyanotech Corporation from a “sell” rating to a “hold” rating in a report on Monday.
Cyanotech Corporation (CYAN) opened at 4.6398 on Tuesday. Cyanotech Corporation has a 12-month low of $3.25 and a 12-month high of $4.75. The stock’s 50 day moving average price is $3.50 and its 200 day moving average price is $3.75. The company’s market capitalization is $26.38 million.
Cyanotech Corporation (NASDAQ:CYAN) last released its earnings results on Thursday, August 10th. The biotechnology company reported $0.09 earnings per share for the quarter. Cyanotech Corporation had a negative net margin of 0.07% and a negative return on equity of 0.14%. The business had revenue of $8.81 million during the quarter. On average, equities research analysts anticipate that Cyanotech Corporation will post ($0.01) earnings per share for the current fiscal year.
Cyanotech Corporation Company Profile
Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.
Receive News & Ratings for Cyanotech Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.